[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "One million US deaths", "description": "US, 1 million deaths this week, 100 million cases this fall and winter\n\n 1918 / 1919\n\nAt least 50 million worldwide\n\n675,000 in the United States\n\n(Population 105 million)\n\nMortality was high in\n\nYounger than 5 years old \n\n20-40 years old \n\n65 years and older \n\nNational Center for Health Statistics\n\nhttps://www.cdc.gov/nchs/index.htm\n\nMore than 1 million deaths \n\nHigher death rate than in any other major industrialized country\n\nhttps://www.medrxiv.org/content/medrxiv/early/2022/02/24/2022.02.23.22271380.full.pdf\n\nLife expectancy, biggest drop since 1918\n\nhttps://www.cdc.gov/mmwr/volumes/71/wr/mm7104e2.htm\n\nOverwhelmingly unvaccinated\n\nMostly old, low income, Black, Hispanic\n\n2020\n\nHeart disease, cancer, Covid\n\nTracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States (Pen State)\n\nhttps://www.pnas.org/doi/10.1073/pnas.2007476117\n\n9 million who have lost a close relative\n\nGrandparent, parent, sibling, spouse, child\n\nUS cases / infections\n\nProbably start to go down from late May\n\nBA.2.12.1 subvariant set to overtake BA.2\n\nCases may increase in the South over summer\n\nBiden administration\n\n100 million infections fall and winter 2022\n\nWaning immunity, vaccines and infections\n\nVariant immune escape\n\nLoosened restrictions\n\nProjections assume omicron and subvariants will continue to dominate community spread\n\nNo dramatically different strain of the virus\n\nSeroprevalence of Infection-Induced SARS-CoV-2 Antibodies \u2014 United States, September 2021\u2013February 2022\n\nhttps://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm\n\nConvenience sample of blood specimens, for anti-N antibodies\n\nAs of February 2022\n\n18 to 49 years, 63.7%\n\n50 to 64 years, 49.8%\n\nOver 65s, 33.2%\n\nChildren and adolescents\n\n75% of had serologic evidence of previous infection\n\nHigh infection rate for Omicron, especially among children. \n\nShould not be interpreted as protection from future infection\n\nVaccination remains the safest strategy for preventing complications from SARS-CoV-2 infection\n\nCOVID-19 Results Briefing, United States of America, April 7, 2022 \n\nhttps://www.healthdata.org/sites/default/files/files/Projects/COVID/2022/102_briefing_United_States_of_America_3.pdf\n\n76% of people in the US have been infected at least once as of April 4\n\nDo not suggest a substantial BA.2 surge in the US\n\nBut if we do, last for 3 weeks\n\nThere is not sufficient evidence at this time that BA.2 spread warrants a broader push on a fourth booster, except in those at high risk. \n\nPfizer and Moderna\n\nWorking on new booster shots\n\nCombine different variants of the virus", "link": "https://www.youtube.com/watch?v=4HWujP60jbc", "date_published": "2022-05-10 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]